Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 28Sanofi-Aventis Canada Inc.
02 19Valeant Canada LP / Valeant Canada S.E.C.
03 24Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 2.5 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 10 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 1.25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 1.25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 2.50 mg per tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 2.50 mg per tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5.00 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 5.00 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 10.00 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
LOOKING FOR A SUPPLIER?